Newsroom > Articles

2023.04

Medexprim’s researchers and engineers contribute daily to the advancement of scientific research.

Examining a series of medical images and identifying organs, as well as characterizing abnormalities such as cancerous nodules (even at early stages), requires extensive experience. However, this can become a tedious task when done routinely. Furthermore, missing even the slightest signs can be detrimental to a patient’s health, making this responsibility highly stressful. AI engines provide a solution for this use case by analyzing medical images more thoroughly, automatically detecting organs, and highlighting subtle or ambiguous signs.

Juliette Bousso points our attention here to a recent study conducted by Zhang and colleagues, where promising results were obtained by training AI models to recognize multiple organs in a single image and alerting specialists to potential nodules.

Read the article

BC Platforms acquires Medexprim, paving the way for Global Leadership…

BC Platforms, a global leader in healthcare data management and analytics, today announced it…

RSNA 2023: Medexprim brings European multi-imaging datasets to Innovation.

Medexprim, a leading European innovator in the field of Real-World Data and healthcare solutions,…

Medexprim appoints Doctor Mercedes Serra as Head of Data Science…

Medexprim is proud to announce the appointment of Mercedes Serra as the Head of…

IQVIA clĂ´ture l’édition 2023 de son Accelerator Program, en collaboration…

IQVIA, spĂ©cialiste mondial d’analyses avancĂ©es, de solutions technologiques et de services de recherche clinique…